Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study

Background: Ventilator-associated pneumonia (VAP) is common in patients with severe SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter observational retrospective study is to assess the relationship between adjuvant corticosteroid use and the incidence of VAP. Method...

Descripción completa

Detalles Bibliográficos
Autores: Saura, Ouriel, Rouzé, Anahita, Martin Loeches, Ignacio, Povoa, Pedro, Kreitmann, Louis, Torres Martí, Antoni, Metzelard, Matthieu, Du Cheyron, Damien, Lambiotte, Fabien, Tamion, Fabienne, Labruyere, Marie, Boulle Geronimi, Claire, Luyt, Charles-Edouard, Nyunga, Martine, Pouly, Olivier, Thille, Arnaud Wilfrid, Megarbane, Bruno, Saade, Anastasia, Magira, Eleni, Llitjos, Jean-François, Ioannidou, Iliana, Pierre, Alexandre, Reignier, Jean, Garot, Denis, Baudel, Jean-Luc, Voiriot, Guillaume, Plantefeve, Gaëtan, Morawiec, Elise, Asfar, Pierre, Boyer, Alexandre, Mekontso-Dessap, Armand, Bardaka, Fotini, Diaz, Emili, Vinsonneau, Christophe, Floch, Pierre-Edouard, Weiss, Nicolas, Ceccato, Adrian, Artigas, Antonio, Nora, David, Duhamel, Alain, Labreuche, Julien, Nseir, Saad, coVAPid Study Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/196208
Acceso en línea:https://hdl.handle.net/2445/196208
Access Level:acceso abierto
Palabra clave:COVID-19
Pneumònia
Corticosteroides
Infeccions respiratòries
Respiració artificial
Respiradors
Pneumonia
Adrenocortical hormones
Respiratory infections
Artificial respiration
Respirators
id ES_26b647a47fc50990b5344cdca8cfdb75
oai_identifier_str oai:recercat.cat:2445/196208
network_acronym_str ES
network_name_str España
repository_id_str
spelling Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter studySaura, OurielRouzé, AnahitaMartin Loeches, IgnacioPovoa, PedroKreitmann, LouisTorres Martí, AntoniMetzelard, MatthieuDu Cheyron, DamienLambiotte, FabienTamion, FabienneLabruyere, MarieBoulle Geronimi, ClaireLuyt, Charles-EdouardNyunga, MartinePouly, OlivierThille, Arnaud WilfridMegarbane, BrunoSaade, AnastasiaMagira, EleniLlitjos, Jean-FrançoisIoannidou, IlianaPierre, AlexandreReignier, JeanGarot, DenisBaudel, Jean-LucVoiriot, GuillaumePlantefeve, GaëtanMorawiec, EliseAsfar, PierreBoyer, AlexandreMekontso-Dessap, ArmandBardaka, FotiniDiaz, EmiliVinsonneau, ChristopheFloch, Pierre-EdouardWeiss, NicolasCeccato, AdrianArtigas, AntonioNora, DavidDuhamel, AlainLabreuche, JulienNseir, SaadcoVAPid Study GroupCOVID-19PneumòniaCorticosteroidesInfeccions respiratòriesRespiració artificialRespiradorsCOVID-19PneumoniaAdrenocortical hormonesRespiratory infectionsArtificial respirationRespiratorsBackground: Ventilator-associated pneumonia (VAP) is common in patients with severe SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter observational retrospective study is to assess the relationship between adjuvant corticosteroid use and the incidence of VAP. Methods: Planned ancillary analysis of a multicenter retrospective European cohort in 36 ICUs. Adult patients receiving invasive mechanical ventilation for more than 48 h for SARS-CoV-2 pneumonia were consecutively included between February and May 2020. VAP diagnosis required strict definition with clinical, radiological and quantitative microbiological confirmation. We assessed the association of VAP with corticosteroid treatment using univariate and multivariate cause-specific Cox's proportional hazard models with adjustment on pre-specified confounders. Results: Among the 545 included patients, 191 (35%) received corticosteroids. The proportional hazard assumption for the effect of corticosteroids on the incidence of VAP could not be accepted, indicating that this effect varied during ICU stay. We found a non-significant lower risk of VAP for corticosteroid-treated patients during the first days in the ICU and an increased risk for longer ICU stay. By modeling the effect of corticosteroids with time-dependent coefficients, the association between corticosteroids and the incidence of VAP was not significant (overall effect p = 0.082), with time-dependent hazard ratios (95% confidence interval) of 0.47 (0.17-1.31) at day 2, 0.95 (0.63-1.42) at day 7, 1.48 (1.01-2.16) at day 14 and 1.94 (1.09-3.46) at day 21. Conclusions: No significant association was found between adjuvant corticosteroid treatment and the incidence of VAP, although a time-varying effect of corticosteroids was identified along the 28-day follow-up.BioMed Central2023202320232023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion11 p.application/pdfhttps://hdl.handle.net/2445/196208Articles publicats en revistes (Medicina)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1186/s13054-022-04170-2Critical Care, 2023, vol. 26, num. 1, p. 292https://doi.org/10.1186/s13054-022-04170-2cc-by (c) Saura, Ouriel et al., 2022https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1962082026-05-29T05:05:01Z
dc.title.none.fl_str_mv Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
title Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
spellingShingle Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
Saura, Ouriel
COVID-19
Pneumònia
Corticosteroides
Infeccions respiratòries
Respiració artificial
Respiradors
COVID-19
Pneumonia
Adrenocortical hormones
Respiratory infections
Artificial respiration
Respirators
title_short Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
title_full Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
title_fullStr Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
title_full_unstemmed Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
title_sort Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study
dc.creator.none.fl_str_mv Saura, Ouriel
Rouzé, Anahita
Martin Loeches, Ignacio
Povoa, Pedro
Kreitmann, Louis
Torres Martí, Antoni
Metzelard, Matthieu
Du Cheyron, Damien
Lambiotte, Fabien
Tamion, Fabienne
Labruyere, Marie
Boulle Geronimi, Claire
Luyt, Charles-Edouard
Nyunga, Martine
Pouly, Olivier
Thille, Arnaud Wilfrid
Megarbane, Bruno
Saade, Anastasia
Magira, Eleni
Llitjos, Jean-François
Ioannidou, Iliana
Pierre, Alexandre
Reignier, Jean
Garot, Denis
Baudel, Jean-Luc
Voiriot, Guillaume
Plantefeve, Gaëtan
Morawiec, Elise
Asfar, Pierre
Boyer, Alexandre
Mekontso-Dessap, Armand
Bardaka, Fotini
Diaz, Emili
Vinsonneau, Christophe
Floch, Pierre-Edouard
Weiss, Nicolas
Ceccato, Adrian
Artigas, Antonio
Nora, David
Duhamel, Alain
Labreuche, Julien
Nseir, Saad
coVAPid Study Group
author Saura, Ouriel
author_facet Saura, Ouriel
Rouzé, Anahita
Martin Loeches, Ignacio
Povoa, Pedro
Kreitmann, Louis
Torres Martí, Antoni
Metzelard, Matthieu
Du Cheyron, Damien
Lambiotte, Fabien
Tamion, Fabienne
Labruyere, Marie
Boulle Geronimi, Claire
Luyt, Charles-Edouard
Nyunga, Martine
Pouly, Olivier
Thille, Arnaud Wilfrid
Megarbane, Bruno
Saade, Anastasia
Magira, Eleni
Llitjos, Jean-François
Ioannidou, Iliana
Pierre, Alexandre
Reignier, Jean
Garot, Denis
Baudel, Jean-Luc
Voiriot, Guillaume
Plantefeve, Gaëtan
Morawiec, Elise
Asfar, Pierre
Boyer, Alexandre
Mekontso-Dessap, Armand
Bardaka, Fotini
Diaz, Emili
Vinsonneau, Christophe
Floch, Pierre-Edouard
Weiss, Nicolas
Ceccato, Adrian
Artigas, Antonio
Nora, David
Duhamel, Alain
Labreuche, Julien
Nseir, Saad
coVAPid Study Group
author_role author
author2 Rouzé, Anahita
Martin Loeches, Ignacio
Povoa, Pedro
Kreitmann, Louis
Torres Martí, Antoni
Metzelard, Matthieu
Du Cheyron, Damien
Lambiotte, Fabien
Tamion, Fabienne
Labruyere, Marie
Boulle Geronimi, Claire
Luyt, Charles-Edouard
Nyunga, Martine
Pouly, Olivier
Thille, Arnaud Wilfrid
Megarbane, Bruno
Saade, Anastasia
Magira, Eleni
Llitjos, Jean-François
Ioannidou, Iliana
Pierre, Alexandre
Reignier, Jean
Garot, Denis
Baudel, Jean-Luc
Voiriot, Guillaume
Plantefeve, Gaëtan
Morawiec, Elise
Asfar, Pierre
Boyer, Alexandre
Mekontso-Dessap, Armand
Bardaka, Fotini
Diaz, Emili
Vinsonneau, Christophe
Floch, Pierre-Edouard
Weiss, Nicolas
Ceccato, Adrian
Artigas, Antonio
Nora, David
Duhamel, Alain
Labreuche, Julien
Nseir, Saad
coVAPid Study Group
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19
Pneumònia
Corticosteroides
Infeccions respiratòries
Respiració artificial
Respiradors
COVID-19
Pneumonia
Adrenocortical hormones
Respiratory infections
Artificial respiration
Respirators
topic COVID-19
Pneumònia
Corticosteroides
Infeccions respiratòries
Respiració artificial
Respiradors
COVID-19
Pneumonia
Adrenocortical hormones
Respiratory infections
Artificial respiration
Respirators
description Background: Ventilator-associated pneumonia (VAP) is common in patients with severe SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter observational retrospective study is to assess the relationship between adjuvant corticosteroid use and the incidence of VAP. Methods: Planned ancillary analysis of a multicenter retrospective European cohort in 36 ICUs. Adult patients receiving invasive mechanical ventilation for more than 48 h for SARS-CoV-2 pneumonia were consecutively included between February and May 2020. VAP diagnosis required strict definition with clinical, radiological and quantitative microbiological confirmation. We assessed the association of VAP with corticosteroid treatment using univariate and multivariate cause-specific Cox's proportional hazard models with adjustment on pre-specified confounders. Results: Among the 545 included patients, 191 (35%) received corticosteroids. The proportional hazard assumption for the effect of corticosteroids on the incidence of VAP could not be accepted, indicating that this effect varied during ICU stay. We found a non-significant lower risk of VAP for corticosteroid-treated patients during the first days in the ICU and an increased risk for longer ICU stay. By modeling the effect of corticosteroids with time-dependent coefficients, the association between corticosteroids and the incidence of VAP was not significant (overall effect p = 0.082), with time-dependent hazard ratios (95% confidence interval) of 0.47 (0.17-1.31) at day 2, 0.95 (0.63-1.42) at day 7, 1.48 (1.01-2.16) at day 14 and 1.94 (1.09-3.46) at day 21. Conclusions: No significant association was found between adjuvant corticosteroid treatment and the incidence of VAP, although a time-varying effect of corticosteroids was identified along the 28-day follow-up.
publishDate 2023
dc.date.none.fl_str_mv 2023
2023
2023
2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/196208
url https://hdl.handle.net/2445/196208
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1186/s13054-022-04170-2
Critical Care, 2023, vol. 26, num. 1, p. 292
https://doi.org/10.1186/s13054-022-04170-2
dc.rights.none.fl_str_mv cc-by (c) Saura, Ouriel et al., 2022
https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Saura, Ouriel et al., 2022
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 11 p.
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404842426892288
score 15,811543